Unn Merete Fagerli

Unn Merete Fagerli is an Associate Professor at the Norwegian University of Science and Technology (NTNU), specializing in hematology and lymphoma research. She leads clinical and translational studies focusing on treatment optimization for hematological malignancies, survivorship care, and imaging biomarkers. Her work spans biomarker development, stem cell transplantation outcomes, and quality-of-life analysis in cancer survivors.

Research Interests

• Lymphoma and multiple myeloma pathogenesis
• Risk-adapted therapy and biomarker-guided treatment
• PET/MRI imaging in oncology
• Clinical outcomes of autologous stem cell transplantation
• Long-term survivorship and late adverse effects

Publications Overview

Her work emphasizes translational research bridging clinical trials and patient outcomes. Notable themes include biomarker-driven lymphoma treatment protocols, comparative imaging modalities (PET/MRI vs PET/CT), and long-term follow-up studies of Hodgkin/non-Hodgkin lymphoma survivors. Recent studies investigate maintenance therapies for primary CNS lymphoma and prognostic factors in aggressive NHL.

Grants & Teams

• Principal investigator in Nordic Lymphoma Group (NLG) trials
• Collaborator on international clinical trials (e.g., IELSG37)
• Member of multidisciplinary teams addressing imaging innovation and survivorship care

Labs & Affiliations

Based at NTNU's Department of Medicine, she collaborates with institutions like the Oslo University Hospital and contributes to national/international oncology networks.